Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase "Multiple immune and tissue cell populations via secreted paracrine factors" refers to a systemic therapeutic mechanism rather than a discrete molecular target or receptor [1]. This terminology is predominantly used in the field of regenerative medicine, specifically by companies like Mesoblast, to describe the pleiotropic effects of mesenchymal stem cells (MSCs) [2]. Instead of a traditional drug-receptor interaction, the therapy relies on the release of a diverse cocktail of "paracrine factors"—including cytokines, chemokines, and extracellular vesicles—that act on various cell types throughout the body [1][3]. These factors work in concert to modulate the activity of T-cells, B-cells, dendritic cells, and macrophages, effectively dampening pathological inflammation and stimulating endogenous tissue repair [3]. This approach is particularly relevant for treating complex, multi-organ inflammatory conditions such as steroid-refractory graft-versus-host disease (SR-aGvHD) and acute respiratory distress syndrome (ARDS) [2]. Because the "target" is a network of cellular interactions rather than a single protein, it represents a shift toward holistic biological modulation in drug development [1]. [1] Galipeau J, Sensébé L. Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell Stem Cell. 2018;22(6):824-833. [2] Mesoblast Limited. FDA Briefing Document: Remestemcel-L. 2020. [3] Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9(1):11-15.
The mechanism involves the therapeutic administration of cells (typically mesenchymal stem cells) that sense inflammatory signals and respond by secreting a broad array of bioactive molecules, such as TGF-beta, PGE2, and IL-10, which simultaneously modulate multiple immune cell subsets and promote tissue regeneration [1][2][3].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple immune and tissue cell populations via secreted paracrine factors.